Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 249

1.

Targeting the thioredoxin system as a novel strategy against B cell acute lymphoblastic leukemia.

Fidyt K, Pastorczak A, Goral A, Szczygiel K, Fendler W, Muchowicz A, Bartlomiejczyk MA, Madzio J, Cyran J, Graczyk-Jarzynka A, Jansen E, Patkowska E, Lech-Maranda E, Pal D, Blair H, Burdzinska A, Pedzisz P, Glodkowska-Mrowka E, Demkow U, Gawle-Krawczyk K, Matysiak M, Winiarska M, Juszczynski P, Mlynarski W, Heidenreich O, Golab J, Firczuk M.

Mol Oncol. 2019 Mar 12. doi: 10.1002/1878-0261.12476. [Epub ahead of print]

2.

GATA3 germline variant is associated with CRLF2 expression and predicts outcome in pediatric B-cell precursor acute lymphoblastic leukemia.

Madzio J, Pastorczak A, Sedek L, Braun M, Taha J, Wypyszczak K, Trelinska J, Lejman M, Muszynska-Roslan K, Tomasik B, Derwich K, Koltan A, Kazanowska B, Irga-Jaworska N, Badowska W, Matysiak M, Kowalczyk J, Styczynski J, Fendler W, Szczepanski T, Mlynarski W.

Genes Chromosomes Cancer. 2019 Mar 11. doi: 10.1002/gcc.22748. [Epub ahead of print]

PMID:
30859636
3.

Dental caries among childhood cancer survivors.

Proc P, Szczepańska J, Herud A, Zubowska M, Fendler W, Młynarski W.

Medicine (Baltimore). 2019 Feb;98(6):e14279. doi: 10.1097/MD.0000000000014279.

4.

Correction to: Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT].

Calais J, Czernin J, Fendler WP, Elashoff D, Nickols NG.

BMC Cancer. 2019 Jan 21;19(1):97. doi: 10.1186/s12885-019-5297-x.

5.

NCOA4 maintains murine erythropoiesis via cell autonomous and non-autonomous mechanisms.

Santana-Codina N, Gableske S, Quiles Del Rey M, Małachowska B, Jedrychowski MP, Biancur DE, Schmidt PJ, Fleming MD, Fendler W, Harper JW, Kimmelman AC, Mancias JD.

Haematologica. 2019 Jan 10. pii: haematol.2018.204123. doi: 10.3324/haematol.2018.204123. [Epub ahead of print]

6.

Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT].

Calais J, Czernin J, Fendler WP, Elashoff D, Nickols NG.

BMC Cancer. 2019 Jan 7;19(1):18. doi: 10.1186/s12885-018-5200-1. Erratum in: BMC Cancer. 2019 Jan 21;19(1):97.

7.

Assessment of right ventricular sympathetic dysfunction in patients with arrhythmogenic right ventricular cardiomyopathy: An 123I-metaiodobenzylguanidine SPECT/CT study.

Todica A, Siebermair J, Schiller J, Zacherl MJ, Fendler WP, Massberg S, Bartenstein P, Cyran CC, Kääb S, Hacker M, Wakili R, Lehner S.

J Nucl Cardiol. 2018 Dec 17. doi: 10.1007/s12350-018-01545-3. [Epub ahead of print]

PMID:
30560521
8.

Impact of 68Ga-PSMA-PET/CT on the radiotherapeutic approach for prostate cancer in comparison to CT - a retrospective analysis.

Schmidt-Hegemann NS, Eze C, Li M, Rogowski P, Schaefer C, Stief C, Buchner A, Zamboglou C, Fendler WP, Ganswindt U, Cyran C, Bartenstein P, Belka C, Ilhan H.

J Nucl Med. 2018 Dec 14. pii: jnumed.118.220855. doi: 10.2967/jnumed.118.220855. [Epub ahead of print]

PMID:
30552203
9.

Meta-analysis of 68Ga-PSMA-11 PET Accuracy for the Detection of Prostate Cancer Validated by Histopathology.

Hope TA, Goodman JZ, Allen IE, Calais J, Fendler WP, Carroll PR.

J Nucl Med. 2018 Dec 7. pii: jnumed.118.219501. doi: 10.2967/jnumed.118.219501. [Epub ahead of print]

PMID:
30530831
10.

Resistance to Data Loss of Glycemic Variability Measurements in Long-Term Continuous Glucose Monitoring.

Kucharski P, Pagacz K, Szadkowska A, Młynarski W, Romanowski A, Fendler W.

Diabetes Technol Ther. 2018 Nov 7. doi: 10.1089/dia.2018.0247. [Epub ahead of print]

PMID:
30403500
11.

[Results of the LuPSMA trial show high response rates with low toxicity and pain relief].

Tschirdewahn S, Fendler WP.

Urologe A. 2018 Dec;57(12):1494-1495. doi: 10.1007/s00120-018-0808-y. German. No abstract available.

PMID:
30397736
12.

Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer.

Lückerath K, Wei L, Fendler WP, Evans-Axelsson S, Stuparu AD, Slavik R, Mona CE, Calais J, Rettig M, Reiter RE, Herrmann K, Radu CG, Czernin J, Eiber M.

EJNMMI Res. 2018 Oct 29;8(1):96. doi: 10.1186/s13550-018-0451-z.

13.

Temporal dynamics of serum let-7g expression mirror the decline of residual beta-cell function in longitudinal observation of children with type 1 diabetes.

Małachowska B, Wyka K, Nowicka Z, Bartłomiejczyk MA, Młynarski W, Fendler W.

Pediatr Diabetes. 2018 Dec;19(8):1407-1415. doi: 10.1111/pedi.12783. Epub 2018 Oct 12.

PMID:
30259606
14.

Optical coherence tomography and magnetic resonance imaging visual pathway evaluation in Wolfram syndrome.

Zmyslowska A, Waszczykowska A, Baranska D, Stawiski K, Borowiec M, Jurowski P, Fendler W, Mlynarski W.

Dev Med Child Neurol. 2019 Mar;61(3):359-365. doi: 10.1111/dmcn.14040. Epub 2018 Sep 23.

PMID:
30246501
15.

Sex hormones and insulin sensitivity in adolescent girls with type 1 diabetes.

Mianowska B, Pietrzak I, Perenc M, Baranowska-Jaźwiecka A, Fendler W, Bodalski J, Młynarski W, Szadkowska A.

Diabetes Metab. 2018 Jul 24. pii: S1262-3636(18)30125-3. doi: 10.1016/j.diabet.2018.07.004. [Epub ahead of print] No abstract available.

PMID:
30093281
16.

Potential of serum microRNAs as biomarkers of radiation injury and tools for individualization of radiotherapy.

Tomasik B, Chałubińska-Fendler J, Chowdhury D, Fendler W.

Transl Res. 2018 Nov;201:71-83. doi: 10.1016/j.trsl.2018.06.001. Epub 2018 Jun 19. Review.

PMID:
30021695
17.

Outcome after PSMA PET/CT based salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: a bi-institutional retrospective analysis.

Schmidt-Hegemann NS, Stief C, Kim TH, Eze C, Kirste S, Strouthos I, Li M, Schultze-Seemann W, Ilhan H, Fendler WP, Bartenstein P, Grosu AL, Ganswindt U, Belka C, Meyer PT, Zamboglou C.

J Nucl Med. 2018 Jul 12. pii: jnumed.118.212563. doi: 10.2967/jnumed.118.212563. [Epub ahead of print]

PMID:
30002108
18.

Five-year observation of the relationship between body mass index and glycated hemoglobin in children with Type 1 diabetes mellitus.

Kadłubiska A, Małachowska B, Noiszewska K, Fendler W, Głowińska-Olszewska B, Bossowski A, Łuczyński W.

Scand J Clin Lab Invest. 2018 Sep;78(5):398-406. doi: 10.1080/00365513.2018.1487073. Epub 2018 Jul 2.

PMID:
29966439
19.

Imaging Prostate Cancer With Prostate-Specific Membrane Antigen PET/CT and PET/MRI: Current and Future Applications.

Hope TA, Afshar-Oromieh A, Eiber M, Emmett L, Fendler WP, Lawhn-Heath C, Rowe SP.

AJR Am J Roentgenol. 2018 Aug;211(2):286-294. doi: 10.2214/AJR.18.19957. Epub 2018 Jun 27.

PMID:
29949419
20.

Surface expression of Cytokine Receptor-Like Factor 2 increases risk of relapse in pediatric acute lymphoblastic leukemia patients harboring IKZF1 deletions.

Pastorczak A, Sedek L, Braun M, Madzio J, Sonsala A, Twardoch M, Fendler W, Nebral K, Taha J, Bielska M, Gorniak P, Romiszewska M, Matysiak M, Derwich K, Lejman M, Kowalczyk J, Badowska W, Niedzwiecki M, Kazanowska B, Muszynska-Roslan K, Sobol-Milejska G, Karolczyk G, Koltan A, Ociepa T, Szczepanski T, Młynarski W.

Oncotarget. 2018 May 25;9(40):25971-25982. doi: 10.18632/oncotarget.25411. eCollection 2018 May 25.

21.

Dual HDAC and PI3K Inhibition Abrogates NFκB- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade Gliomas.

Pal S, Kozono D, Yang X, Fendler W, Fitts W, Ni J, Alberta JA, Zhao J, Liu KX, Bian J, Truffaux N, Weiss WA, Resnick AC, Bandopadhayay P, Ligon KL, DuBois SG, Mueller S, Chowdhury D, Haas-Kogan DA.

Cancer Res. 2018 Jul 15;78(14):4007-4021. doi: 10.1158/0008-5472.CAN-17-3691. Epub 2018 May 14.

22.

Meeting report from the Prostate Cancer Foundation PSMA-directed radionuclide scientific working group.

Miyahira AK, Pienta KJ, Morris MJ, Bander NH, Baum RP, Fendler WP, Goeckeler W, Gorin MA, Hennekes H, Pomper MG, Sartor O, Tagawa ST, Williams S, Soule HR.

Prostate. 2018 Aug;78(11):775-789. doi: 10.1002/pros.23642. Epub 2018 May 1. Review.

PMID:
29717499
23.

Effect of stroke thrombolysis predicted by distal vessel occlusion detection.

Kunz WG, Fabritius MP, Sommer WH, Höhne C, Scheffler P, Rotkopf LT, Fendler WP, Sabel BO, Meinel FG, Dorn F, Ertl-Wagner B, Reiser MF, Thierfelder KM.

Neurology. 2018 May 15;90(20):e1742-e1750. doi: 10.1212/WNL.0000000000005519. Epub 2018 Apr 20.

PMID:
29678936
24.

Potential Impact of 68Ga-PSMA-11 PET/CT on the Planning of Definitive Radiation Therapy for Prostate Cancer.

Calais J, Kishan AU, Cao M, Fendler WP, Eiber M, Herrmann K, Ceci F, Reiter RE, Rettig MB, Hegde JV, Shaverdian N, King CR, Steinberg ML, Czernin J, Nickols NG.

J Nucl Med. 2018 Nov;59(11):1714-1721. doi: 10.2967/jnumed.118.209387. Epub 2018 Apr 13.

PMID:
29653978
25.

GlyCulator2: an update on a web application for calculation of glycemic variability indices.

Pagacz K, Stawiski K, Szadkowska A, Mlynarski W, Fendler W.

Acta Diabetol. 2018 Aug;55(8):877-880. doi: 10.1007/s00592-018-1140-0. Epub 2018 Apr 13. No abstract available.

PMID:
29651558
26.

Detection Threshold and Reproducibility of 68Ga-PSMA11 PET/CT in a Mouse Model of Prostate Cancer.

Lückerath K, Stuparu AD, Wei L, Kim W, Radu CG, Mona CE, Calais J, Rettig M, Reiter RE, Czernin J, Slavik R, Herrmann K, Eiber M, Fendler WP.

J Nucl Med. 2018 Sep;59(9):1392-1397. doi: 10.2967/jnumed.118.207704. Epub 2018 Mar 30.

PMID:
29602819
27.

Serum microRNAs - potent biomarkers for radiation biodosimetry.

Tomasik B, Fendler W, Chowdhury D.

Oncotarget. 2018 Feb 2;9(18):14038-14039. doi: 10.18632/oncotarget.24381. eCollection 2018 Mar 6. No abstract available.

28.

Upregulation of FOXP1 is a new independent unfavorable prognosticator and a specific predictor of lymphatic dissemination in cutaneous melanoma patients.

Donizy P, Pagacz K, Marczuk J, Fendler W, Maciejczyk A, Halon A, Matkowski R.

Onco Targets Ther. 2018 Mar 14;11:1413-1422. doi: 10.2147/OTT.S151286. eCollection 2018.

29.

Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy.

Schmidt-Hegemann NS, Fendler WP, Ilhan H, Herlemann A, Buchner A, Stief C, Eze C, Rogowski P, Li M, Bartenstein P, Ganswindt U, Belka C.

Radiat Oncol. 2018 Mar 2;13(1):37. doi: 10.1186/s13014-018-0983-4.

30.

Reply: Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective Trial Is on Its Way.

Calais J, Fendler WP, Herrmann K, Eiber M, Ceci F.

J Nucl Med. 2018 May;59(5):861. doi: 10.2967/jnumed.118.209965. Epub 2018 Mar 1. No abstract available.

PMID:
29496985
31.

Heterozygous carriers of germline c.657_661del5 founder mutation in NBN gene are at risk of central nervous system relapse of B-cell precursor acute lymphoblastic leukemia.

Tomasik B, Pastorczak A, Fendler W, Bartłomiejczyk M, Braun M, Mycko M, Madzio J, Polakowska E, Ulińska E, Matysiak M, Derwich K, Lejman M, Kowalczyk J, Badowska W, Kazanowska B, Szczepański T, Styczyński J, Irga-Jaworska N, Młynarski W; Polish Pediatric Leukemia/Lymphoma Study Group (PPLLSG).

Haematologica. 2018 May;103(5):e200-e203. doi: 10.3324/haematol.2017.181198. Epub 2018 Feb 1. No abstract available.

32.

Neoadjuvant chemoradiation for esophageal cancer : Surgery improves locoregional control while response based on FDG-PET/CT predicts survival.

Hegemann NS, Koepple R, Walter F, Boeckle D, Fendler WP, Angele MK, Boeck S, Belka C, Roeder F.

Strahlenther Onkol. 2018 May;194(5):435-443. doi: 10.1007/s00066-018-1261-y. Epub 2018 Jan 18.

PMID:
29349603
33.

A prototypical non-malignant epithelial model to study genome dynamics and concurrently monitor micro-RNAs and proteins in situ during oncogene-induced senescence.

Komseli ES, Pateras IS, Krejsgaard T, Stawiski K, Rizou SV, Polyzos A, Roumelioti FM, Chiourea M, Mourkioti I, Paparouna E, Zampetidis CP, Gumeni S, Trougakos IP, Pefani DE, O'Neill E, Gagos S, Eliopoulos AG, Fendler W, Chowdhury D, Bartek J, Gorgoulis VG.

BMC Genomics. 2018 Jan 10;19(1):37. doi: 10.1186/s12864-017-4375-1.

34.

Perforin gene variation influences survival in childhood acute lymphoblastic leukemia.

Jaworowska A, Pastorczak A, Trelinska J, Wypyszczak K, Borowiec M, Fendler W, Sedek L, Szczepanski T, Ploski R, Młynarski W.

Leuk Res. 2018 Feb;65:29-33. doi: 10.1016/j.leukres.2017.12.011. Epub 2018 Jan 2.

PMID:
29304394
35.

Effects of cell-cell crosstalk on gene expression patterns in a cell model of renal cell carcinoma lung metastasis.

Kaminska K, Czarnecka AM, Khan MI, Fendler W, Klemba A, Krasowski P, Bartnik E, Szczylik C.

Int J Oncol. 2018 Mar;52(3):768-786. doi: 10.3892/ijo.2017.4234. Epub 2017 Dec 29.

36.

Coexisting psoriasis affects the clinical course of type 1 diabetes in children.

Michalak A, Koptas M, Świercz A, Wyka K, Hogendorf A, Szadkowska A, Młynarski W, Fendler W.

Pediatr Endocrinol Diabetes Metab. 2017;23(3):139-145. doi: 10.18544/PEDM-23.03.0085.

PMID:
29253034
37.

Effect of Arsenic Exposure on NRF2-KEAP1 Pathway and Epigenetic Modification.

Janasik B, Reszka E, Stanislawska M, Jablonska E, Kuras R, Wieczorek E, Malachowska B, Fendler W, Wasowicz W.

Biol Trace Elem Res. 2018 Sep;185(1):11-19. doi: 10.1007/s12011-017-1219-4. Epub 2017 Dec 15.

38.

Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence.

Calais J, Fendler WP, Herrmann K, Eiber M, Ceci F.

J Nucl Med. 2018 May;59(5):789-794. doi: 10.2967/jnumed.117.203257. Epub 2017 Dec 14.

PMID:
29242404
39.

A New Type of Prostate Cancer Imaging: Will 64CuCl2 PET/CT Flourish or Vanish?

Ceci F, Fendler W, Eiber M.

J Nucl Med. 2018 Mar;59(3):442-443. doi: 10.2967/jnumed.117.199885. Epub 2017 Dec 14. No abstract available.

40.

Impact of 68Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence.

Calais J, Fendler WP, Eiber M, Gartmann J, Chu FI, Nickols NG, Reiter RE, Rettig MB, Marks LS, Ahlering TE, Huynh LM, Slavik R, Gupta P, Quon A, Allen-Auerbach MS, Czernin J, Herrmann K.

J Nucl Med. 2018 Mar;59(3):434-441. doi: 10.2967/jnumed.117.202945. Epub 2017 Dec 14.

41.

Flash Glucose Measurements in Children with Type 1 Diabetes in Real-Life Settings: To Trust or Not to Trust?

Szadkowska A, Gawrecki A, Michalak A, Zozulińska-Ziółkiewicz D, Fendler W, Młynarski W.

Diabetes Technol Ther. 2018 Jan;20(1):17-24. doi: 10.1089/dia.2017.0287. Epub 2017 Dec 13.

PMID:
29235898
42.

Salvage lymph node dissection after 68Ga-PSMA or 18F-FEC PET/CT for nodal recurrence in prostate cancer patients.

Herlemann A, Kretschmer A, Buchner A, Karl A, Tritschler S, El-Malazi L, Fendler WP, Wenter V, Ilhan H, Bartenstein P, Stief CG, Gratzke C.

Oncotarget. 2017 Sep 21;8(48):84180-84192. doi: 10.18632/oncotarget.21118. eCollection 2017 Oct 13.

43.

Detection level and pattern of positive lesions using PSMA PET/CT for staging prior to radiation therapy.

Schmidt-Hegemann NS, Fendler WP, Buchner A, Stief C, Rogowski P, Niyazi M, Eze C, Li M, Bartenstein P, Belka C, Ganswindt U.

Radiat Oncol. 2017 Nov 10;12(1):176. doi: 10.1186/s13014-017-0902-0.

44.

68Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning.

Calais J, Czernin J, Cao M, Kishan AU, Hegde JV, Shaverdian N, Sandler K, Chu FI, King CR, Steinberg ML, Rauscher I, Schmidt-Hegemann NS, Poeppel T, Hetkamp P, Ceci F, Herrmann K, Fendler WP, Eiber M, Nickols NG.

J Nucl Med. 2018 Feb;59(2):230-237. doi: 10.2967/jnumed.117.201749. Epub 2017 Nov 9.

45.

Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT.

Eiber M, Herrmann K, Calais J, Hadaschik B, Giesel FL, Hartenbach M, Hope T, Reiter R, Maurer T, Weber WA, Fendler WP.

J Nucl Med. 2018 Mar;59(3):469-478. doi: 10.2967/jnumed.117.198119. Epub 2017 Nov 9. Erratum in: J Nucl Med. 2018 Jun;59(6):992.

46.

Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer.

Elias KM, Fendler W, Stawiski K, Fiascone SJ, Vitonis AF, Berkowitz RS, Frendl G, Konstantinopoulos P, Crum CP, Kedzierska M, Cramer DW, Chowdhury D.

Elife. 2017 Oct 31;6. pii: e28932. doi: 10.7554/eLife.28932.

47.

Markers influencing the presence of partial clinical remission in patients with newly diagnosed type 1 diabetes.

Pyziak A, Zmyslowska A, Bobeff K, Malachowska B, Fendler W, Wyka K, Baranowska-Jazwiecka A, Szymanska M, Szadkowska A, Mlynarski W.

J Pediatr Endocrinol Metab. 2017 Oct 26;30(11):1147-1153. doi: 10.1515/jpem-2017-0100.

PMID:
29016353
48.

More α Than β for Prostate Cancer?

Fendler WP, Cutler C.

J Nucl Med. 2017 Nov;58(11):1709-1710. doi: 10.2967/jnumed.117.198333. Epub 2017 Sep 21. No abstract available.

49.

Serum Metabolic Fingerprinting Identified Putatively Annotated Sphinganine Isomer as a Biomarker of Wolfram Syndrome.

Zmyslowska A, Ciborowski M, Borowiec M, Fendler W, Pietrowska K, Parfieniuk E, Antosik K, Pyziak A, Waszczykowska A, Kretowski A, Mlynarski W.

J Proteome Res. 2017 Nov 3;16(11):4000-4008. doi: 10.1021/acs.jproteome.7b00401.

PMID:
28895401
50.

Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy.

Eiber M, Fendler WP, Rowe SP, Calais J, Hofman MS, Maurer T, Schwarzenboeck SM, Kratowchil C, Herrmann K, Giesel FL.

J Nucl Med. 2017 Sep;58(Suppl 2):67S-76S. doi: 10.2967/jnumed.116.186767. Review.

Supplemental Content

Loading ...
Support Center